Cargando…

Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya

BACKGROUND: Lymphatic filariasis (LF) is a debilitating disease associated with extensive disfigurement and is one of a diverse group of diseases referred to as neglected tropical diseases (NTDs) which mainly occur among the poorest populations. In line with global recommendations to eliminate LF, K...

Descripción completa

Detalles Bibliográficos
Autores principales: Njenga, Sammy M., Kanyi, Henry M., Mutungi, Faith M., Okoyo, Collins, Matendechero, Hadley S., Pullan, Rachel L., Halliday, Katherine E., Brooker, Simon J., Wamae, C. Njeri, Onsongo, Joyce K., Won, Kimberly Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322668/
https://www.ncbi.nlm.nih.gov/pubmed/28228160
http://dx.doi.org/10.1186/s13071-017-2044-5
_version_ 1782509893852332032
author Njenga, Sammy M.
Kanyi, Henry M.
Mutungi, Faith M.
Okoyo, Collins
Matendechero, Hadley S.
Pullan, Rachel L.
Halliday, Katherine E.
Brooker, Simon J.
Wamae, C. Njeri
Onsongo, Joyce K.
Won, Kimberly Y.
author_facet Njenga, Sammy M.
Kanyi, Henry M.
Mutungi, Faith M.
Okoyo, Collins
Matendechero, Hadley S.
Pullan, Rachel L.
Halliday, Katherine E.
Brooker, Simon J.
Wamae, C. Njeri
Onsongo, Joyce K.
Won, Kimberly Y.
author_sort Njenga, Sammy M.
collection PubMed
description BACKGROUND: Lymphatic filariasis (LF) is a debilitating disease associated with extensive disfigurement and is one of a diverse group of diseases referred to as neglected tropical diseases (NTDs) which mainly occur among the poorest populations. In line with global recommendations to eliminate LF, Kenya launched its LF elimination programme in 2002 with the aim to implement annual mass drug administration (MDA) in order to interrupt LF transmission. However, the programme faced financial and administrative challenges over the years such that sustained annual MDA was not possible. Recently, there has been renewed interest to eliminate LF and the Kenyan Ministry of Health, through support from World Health Organization (WHO), restarted annual MDA in 2015. The objective of this study was to evaluate the current status of LF infection in the endemic coastal region of Kenya before MDA campaigns were restarted. RESULTS: Ten sentinel sites in Kwale, Kilifi, Tana River, Lamu, and Taita-Taveta counties in coastal Kenya were selected for participation in a cross-sectional survey of LF infection prevalence. At least 300 individuals in each sentinel village were sampled through random house-to-house visits. During the day, the point-of-care immunochromatographic test (ICT) was used to detect the presence of Wuchereria bancrofti circulating filarial antigen in finger prick blood samples collected from residents of the selected sentinel villages. Those individuals who tested positive with the ICT test were requested to provide a night-time blood sample for microfilariae (MF) examination. The overall prevalence of filarial antigenaemia was 1.3% (95% CI: 0.9–1.8%). Ndau Island in Lamu County had the highest prevalence (6.3%; 95% CI: 4.1–9.7%), whereas sites in Kilifi and Kwale counties had prevalences < 1.7%. Mean microfilarial density was also higher in Ndau Island (234 MF/ml) compared to sentinel sites in Kwale and Kilifi counties (< 25 MF/ml). No LF infection was detected in Tana River and Taita-Taveta counties. Overall, more than 88% of the study participants reported to have used a bed net the previous night. CONCLUSIONS: Prevalence of LF infection is generally very low in coastal Kenya, but there remain areas that require further rounds of MDA if the disease is to be eliminated as a public health problem in line with the ongoing global elimination efforts. However, areas where there was no evidence of LF transmission should be considered for WHO-recommended transmission assessment surveys in view of stopping MDA.
format Online
Article
Text
id pubmed-5322668
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53226682017-03-01 Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya Njenga, Sammy M. Kanyi, Henry M. Mutungi, Faith M. Okoyo, Collins Matendechero, Hadley S. Pullan, Rachel L. Halliday, Katherine E. Brooker, Simon J. Wamae, C. Njeri Onsongo, Joyce K. Won, Kimberly Y. Parasit Vectors Research BACKGROUND: Lymphatic filariasis (LF) is a debilitating disease associated with extensive disfigurement and is one of a diverse group of diseases referred to as neglected tropical diseases (NTDs) which mainly occur among the poorest populations. In line with global recommendations to eliminate LF, Kenya launched its LF elimination programme in 2002 with the aim to implement annual mass drug administration (MDA) in order to interrupt LF transmission. However, the programme faced financial and administrative challenges over the years such that sustained annual MDA was not possible. Recently, there has been renewed interest to eliminate LF and the Kenyan Ministry of Health, through support from World Health Organization (WHO), restarted annual MDA in 2015. The objective of this study was to evaluate the current status of LF infection in the endemic coastal region of Kenya before MDA campaigns were restarted. RESULTS: Ten sentinel sites in Kwale, Kilifi, Tana River, Lamu, and Taita-Taveta counties in coastal Kenya were selected for participation in a cross-sectional survey of LF infection prevalence. At least 300 individuals in each sentinel village were sampled through random house-to-house visits. During the day, the point-of-care immunochromatographic test (ICT) was used to detect the presence of Wuchereria bancrofti circulating filarial antigen in finger prick blood samples collected from residents of the selected sentinel villages. Those individuals who tested positive with the ICT test were requested to provide a night-time blood sample for microfilariae (MF) examination. The overall prevalence of filarial antigenaemia was 1.3% (95% CI: 0.9–1.8%). Ndau Island in Lamu County had the highest prevalence (6.3%; 95% CI: 4.1–9.7%), whereas sites in Kilifi and Kwale counties had prevalences < 1.7%. Mean microfilarial density was also higher in Ndau Island (234 MF/ml) compared to sentinel sites in Kwale and Kilifi counties (< 25 MF/ml). No LF infection was detected in Tana River and Taita-Taveta counties. Overall, more than 88% of the study participants reported to have used a bed net the previous night. CONCLUSIONS: Prevalence of LF infection is generally very low in coastal Kenya, but there remain areas that require further rounds of MDA if the disease is to be eliminated as a public health problem in line with the ongoing global elimination efforts. However, areas where there was no evidence of LF transmission should be considered for WHO-recommended transmission assessment surveys in view of stopping MDA. BioMed Central 2017-02-22 /pmc/articles/PMC5322668/ /pubmed/28228160 http://dx.doi.org/10.1186/s13071-017-2044-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Njenga, Sammy M.
Kanyi, Henry M.
Mutungi, Faith M.
Okoyo, Collins
Matendechero, Hadley S.
Pullan, Rachel L.
Halliday, Katherine E.
Brooker, Simon J.
Wamae, C. Njeri
Onsongo, Joyce K.
Won, Kimberly Y.
Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
title Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
title_full Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
title_fullStr Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
title_full_unstemmed Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
title_short Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
title_sort assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal kenya
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322668/
https://www.ncbi.nlm.nih.gov/pubmed/28228160
http://dx.doi.org/10.1186/s13071-017-2044-5
work_keys_str_mv AT njengasammym assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT kanyihenrym assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT mutungifaithm assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT okoyocollins assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT matendecherohadleys assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT pullanrachell assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT hallidaykatherinee assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT brookersimonj assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT wamaecnjeri assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT onsongojoycek assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya
AT wonkimberlyy assessmentoflymphaticfilariasispriortorestartingmassdrugadministrationcampaignsincoastalkenya